PapersFlow Research Brief
Electroconvulsive Therapy Studies
Research Guide
What is Electroconvulsive Therapy Studies?
Electroconvulsive Therapy Studies is a body of research examining the efficacy, safety, mechanisms of action, cognitive effects, and associations of electroconvulsive therapy (ECT) with conditions like depression, bipolar disorder, catatonia, neuroleptic malignant syndrome, and serotonin syndrome.
This field includes 39,503 papers on ECT's role in treating psychiatric conditions such as depression and bipolar disorder. Studies address cognitive effects and hippocampal volume changes following ECT, alongside alternatives like magnetic seizure therapy. Research also investigates links between ECT and serotonin syndrome.
Topic Hierarchy
Research Sub-Topics
Efficacy of Electroconvulsive Therapy in Major Depression
Meta-analyses and RCTs assess remission rates, response speed, and relapse prevention of ECT versus pharmacotherapy in treatment-resistant depression. Studies examine electrode placement, seizure parameters, and augmentation strategies.
Cognitive Side Effects of Electroconvulsive Therapy
Research tracks retrograde amnesia, executive function deficits, and recovery trajectories post-ECT using neuropsychological batteries. Investigations test ultrabrief pulse widths and maintenance regimens to minimize impairment.
Mechanisms of Action of Electroconvulsive Therapy
Neuroimaging and preclinical studies explore ECT-induced BDNF upregulation, hippocampal neurogenesis, and monoamine modulation. Human trials link seizure quality to volumetric changes and neurotransmitter alterations.
Electroconvulsive Therapy in Catatonia
Clinical series and guidelines evaluate ECT response rates in malignant and non-malignant catatonia across psychiatric and medical etiologies. Research compares ECT to benzodiazepines and identifies predictors of remission.
Magnetic Seizure Therapy as ECT Alternative
Controlled trials compare magnetic seizure therapy (MST) to ECT for antidepressant efficacy with reduced cognitive side effects using focal magnetic stimulation. Feasibility studies assess skull penetration and seizure induction parameters.
Why It Matters
Electroconvulsive therapy studies demonstrate ECT's efficacy in severe depressive disorders, as shown in the systematic review and meta-analysis "Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis" (2003), which analyzed multiple trials to confirm benefits over other treatments in resistant cases. In bipolar disorder, papers like "Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative" by Merikangas et al. (2011, 2549 citations) highlight prevalence and comorbidity patterns that underscore ECT's relevance for severe presentations. Mechanisms are detailed in "Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments" by Nibuya et al. (1995, 2091 citations), where chronic electroconvulsive seizures increased BDNF mRNA twofold in rat frontal cortex, supporting ECT's neurotrophic effects in treatment-resistant depression.
Reading Guide
Where to Start
"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis" (2003) is the starting point for beginners, as it synthesizes clinical evidence on ECT's core benefits and risks in depression through meta-analysis of trials.
Key Papers Explained
"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments" by Nibuya et al. (1995) establishes molecular mechanisms of ECS-induced BDNF upregulation. This foundational work informs clinical papers like "Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis" (2003), which builds efficacy evidence on such mechanisms. "Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative" by Merikangas et al. (2011) extends context to bipolar applications, while "The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder" by Judd et al. (2002) details chronicity driving ECT use.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Field frontiers include cognitive effects and hippocampal changes post-ECT, serotonin syndrome risks, and magnetic seizure therapy comparisons, based on keyword emphases without recent preprints or news.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Prevalence and Correlates of Bipolar Spectrum Disorder in the ... | 2011 | Archives of General Ps... | 2.5K | ✓ |
| 2 | Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyo... | 2015 | New England Journal of... | 2.4K | ✓ |
| 3 | Regulation of BDNF and trkB mRNA in rat brain by chronic elect... | 1995 | Journal of Neuroscience | 2.1K | ✓ |
| 4 | The Long-term Natural History of the Weekly Symptomatic Status... | 2002 | Archives of General Ps... | 2.1K | ✕ |
| 5 | Antidepressant Drug Effects and Depression Severity | 2010 | JAMA | 2.0K | ✕ |
| 6 | Handbook of Experimental Pharmacology. | 1971 | Archives of Internal M... | 2.0K | ✕ |
| 7 | The Serotonin Syndrome | 2005 | New England Journal of... | 1.8K | ✕ |
| 8 | The UKU side effect rating scale: A new comprehensive rating s... | 1987 | Acta Psychiatrica Scan... | 1.7K | ✕ |
| 9 | Efficacy and safety of electroconvulsive therapy in depressive... | 2003 | The Lancet | 1.6K | ✕ |
| 10 | Comparative efficacy and acceptability of 12 new-generation an... | 2009 | The Lancet | 1.6K | ✕ |
Frequently Asked Questions
What mechanisms underlie electroconvulsive therapy's antidepressant effects?
Chronic electroconvulsive seizure increases BDNF mRNA approximately twofold and trkB mRNA in rat frontal cortex and hippocampus, as shown by in situ hybridization. This regulation parallels antidepressant drug treatments. "Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments" by Nibuya et al. (1995) provides evidence for neurotrophic mechanisms.
How effective is ECT in depressive disorders?
"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis" (2003) confirms ECT's efficacy through pooled data from randomized trials. It outperforms sham ECT and pharmacotherapy in severe cases. Safety profiles support its use in treatment-resistant depression.
What is the association between ECT and serotonin syndrome?
ECT studies explore links to serotonin syndrome, a potentially life-threatening reaction from drug interactions or therapeutic use. "The Serotonin Syndrome" by Boyer and Shannon (2005, 1788 citations) describes its features in contexts relevant to ECT patients on serotonergic medications. Monitoring is essential during ECT courses.
What cognitive effects are associated with ECT?
Research in this field examines cognitive side effects of ECT, including memory changes. The cluster description notes investigations into hippocampal volume alterations post-ECT. Scales like the UKU side effect rating assess psychotropic impacts in neuroleptic-treated patients, applicable to ECT monitoring.
What alternatives to traditional ECT exist?
Magnetic seizure therapy is studied as a safer alternative to ECT with potentially fewer cognitive effects. Keyword analysis in the field highlights this modality for psychiatric treatments. It targets similar seizure induction with focused magnetic fields.
How prevalent is bipolar disorder in ECT studies context?
Bipolar spectrum disorder shows cross-site prevalence variation but consistent severity and comorbidity internationally. "Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative" by Merikangas et al. (2011, 2549 citations) reports uniform increases in suicidal behavior across categories. This supports ECT's role in acute bipolar management.
Open Research Questions
- ? How do ECT-induced changes in hippocampal volume correlate with long-term cognitive outcomes in depression patients?
- ? What factors mediate the risk of serotonin syndrome in patients receiving ECT alongside serotonergic agents?
- ? In what ways does magnetic seizure therapy differ from ECT in efficacy for catatonia and neuroleptic malignant syndrome?
- ? What are the precise neurotrophic pathways activated by ECT versus antidepressants in bipolar disorder?
- ? How do subsyndromal symptoms in bipolar I disorder influence ECT response rates?
Recent Trends
The field encompasses 39,503 works with no specified 5-year growth rate; top-cited papers from 1995-2011 dominate, including Nibuya et al. (1995, 2091 citations) on BDNF regulation and the 2003 Lancet meta-analysis (1644 citations) on ECT efficacy, indicating sustained focus on core mechanisms and depression applications absent recent preprints.
Research Electroconvulsive Therapy Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Electroconvulsive Therapy Studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers